Annexon, Inc. (ANNX) vs Olema Pharmaceuticals, Inc. (OLMA)
A side-by-side comparison of Annexon, Inc. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANNX
Annexon, Inc.
$4.06HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
OLMA
Olema Pharmaceuticals, Inc.
$7.88HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — ANNX vs OLMA
growth of $100 · dividends reinvested · last 6yANNX -82.3% (-25.1%/yr)OLMA -83.2% (-25.7%/yr)ANNX compounded faster over this window
ANNX OLMA
ANNX vs OLMA: by the numbers
- •OLMA is the larger company ($688M vs $665M market cap).
Metrics side by side
Valuation
| Metric | ANNX | OLMA |
|---|---|---|
| P/B ratio | 3.57 | 1.60 |
Profitability
| Metric | ANNX | OLMA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -108.93% | -47.51% |
| ROIC | -101.43% | -50.92% |
Growth (annualized)
| Metric | ANNX | OLMA |
|---|---|---|
| Total return CAGR (5Y) | -26.29% | -21.50% |
Frequently asked
- How have ANNX and OLMA total returns compared?
- Over the past 5 years, ANNX delivered -26.29% and OLMA delivered -21.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.